Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J E Mortimer

Showing results (11-20 of 23) with videos related to

Pageof 3
Sort By:
Cancer|March 1, 1992
A phase II randomized study comparing sequential and combined intraarterial cisplatin and radiation therapy in primary brain tumors. A Southwest Oncology Group studyJ E Mortimer, J Crowley, H Eyre, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 20, 1999
Effect of tamoxifen on sexual functioning in patients with breast cancerJ E Mortimer, L Boucher, J Baty, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 2, 2001
Metabolic flare: indicator of hormone responsiveness in advanced breast cancerJ E Mortimer, F Dehdashti, B A Siegel, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 1, 1996
Positron emission tomography with 2-[18F]Fluoro-2-deoxy-D-glucose and 16alpha-[18F]fluoro-17beta-estradiol in breast cancer: correlation with estrogen receptor status and response to systemic therapyJ E Mortimer, F Dehdashti, B A Siegel, et al.
International Journal of Radiation Oncology, Biology, Physics|December 1, 1996
Results of a trial with topotecan dose escalation and concurrent thoracic radiation therapy for locally advanced, inoperable nonsmall cell lung cancerM V Graham, M Jahanzeb, C M Dresler, et al.
European Journal of Nuclear Medicine|February 6, 1999
Positron emission tomographic assessment of "metabolic flare" to predict response of metastatic breast cancer to antiestrogen therapyF Dehdashti, F L Flanagan, J E Mortimer, et al.
Cancer|February 15, 1990
High-dose cisplatin for metastatic soft tissue sarcomaG T Budd, B Metch, S P Balcerzak, et al.
Cancer|July 1, 1994
Management of locally advanced carcinoma of the breast. I. NoninflammatoryC A Perez, M L Graham, M E Taylor, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 1, 1992
A phase III randomized study comparing cisplatin and fluorouracil as single agents and in combination for advanced squamous cell carcinoma of the head and neckC Jacobs, G Lyman, E Velez-García, et al.
International Journal of Radiation Oncology, Biology, Physics|February 15, 1995
Factors influencing cosmetic results after conservation therapy for breast cancerM E Taylor, C A Perez, K J Halverson, et al.
Pageof 3

Showing results (11-20 of 23) with videos related to

Sort By:
Pageof 3
Cancer|March 1, 1992
A phase II randomized study comparing sequential and combined intraarterial cisplatin and radiation therapy in primary brain tumors. A Southwest Oncology Group studyJ E Mortimer, J Crowley, H Eyre, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 20, 1999
Effect of tamoxifen on sexual functioning in patients with breast cancerJ E Mortimer, L Boucher, J Baty, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 2, 2001
Metabolic flare: indicator of hormone responsiveness in advanced breast cancerJ E Mortimer, F Dehdashti, B A Siegel, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 1, 1996
Positron emission tomography with 2-[18F]Fluoro-2-deoxy-D-glucose and 16alpha-[18F]fluoro-17beta-estradiol in breast cancer: correlation with estrogen receptor status and response to systemic therapyJ E Mortimer, F Dehdashti, B A Siegel, et al.
International Journal of Radiation Oncology, Biology, Physics|December 1, 1996
Results of a trial with topotecan dose escalation and concurrent thoracic radiation therapy for locally advanced, inoperable nonsmall cell lung cancerM V Graham, M Jahanzeb, C M Dresler, et al.
European Journal of Nuclear Medicine|February 6, 1999
Positron emission tomographic assessment of "metabolic flare" to predict response of metastatic breast cancer to antiestrogen therapyF Dehdashti, F L Flanagan, J E Mortimer, et al.
Cancer|February 15, 1990
High-dose cisplatin for metastatic soft tissue sarcomaG T Budd, B Metch, S P Balcerzak, et al.
Cancer|July 1, 1994
Management of locally advanced carcinoma of the breast. I. NoninflammatoryC A Perez, M L Graham, M E Taylor, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 1, 1992
A phase III randomized study comparing cisplatin and fluorouracil as single agents and in combination for advanced squamous cell carcinoma of the head and neckC Jacobs, G Lyman, E Velez-García, et al.
International Journal of Radiation Oncology, Biology, Physics|February 15, 1995
Factors influencing cosmetic results after conservation therapy for breast cancerM E Taylor, C A Perez, K J Halverson, et al.
Pageof 3